NASDAQ:ARIA Investor Alert: Lawsuit Alleges Misleading Statements by Ariad Pharmaceuticals, Inc.
An investor, who purchased shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Ariad Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between December 12, 2011 and October 8, 2013.
View full press release